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When injected intracerebrally (i.c.),' lymphocytic choriomeningitis virus
(LCMV) usually causes a lethal lymphocytic choriomeningitis (LCM) in mice (1,
2). This disease has been shown (1-4) to be Tcell mediated; immunocompetent
mice develop LCM and die, whereas T cell-deficient mice survive. Susceptibility
ofmice to LCM disease depends upon the degree of T cell immunocompetence
ofthe host, and varies with host genes (5, 6) and with different virus isolates (1,
2, 7). Since i.c. infections do not usually occur in nature, except for possible
routing via the olfactory nerves, the model has been criticized as being artificial
and therefore of questionable relevance. Although LCMV injected i.v. or i.p.
only occasionally kills mice, they show varying signs ofclinical disease during the
course ofthe infection (1, 2, 6, 8-10).
In this report, we analyze the hepatitis caused in mice by hepatotropic LCMV
(1, 2, 9, 10), by monitoring liver histology and the serum concentration of
enzymes signalling liver cell destruction (i.e., alanine aminotransferase [ALT],
glutamate dehydrogenase [GLDH], and less specific aspartate aminotransferase
[AST]), or liver cell repair (i.e., alkaline phosphatase [AP]). We show that the
liver cell damage is T cell mediated, independent of B cells and antibodies, and
correlates best with the cytotoxic T cell activity in livers. LCMV-specific Lyt-2+,
H-2K,D-restricted T cells that were cytolytic in vitro caused, upon adoptive
transfer, a dose- and time-dependent linear increase in serum enzyme levels in
vivo. These data represent a physiological in vivo correlate of the "Cr-release
assay in vitro, and give direct evidence that antiviral effector T cells act cytolyti-
cally in vivo. Overall, this virus-triggered but T cell-mediated liver disease
resembles the pathophysiology of acute hepatitis B virus infections in man (11-
13), and therefore may serve as an animal model ofits immunological pathogen-
esis.
This work was supported by grant SNF 3.323-0.82 from the Swiss National Science Foundation, in
part by grant AI 17284-05 from the National Institutes of Health, Bethesda, MD, and by the Kanton
of Zurich.
' Abbreviations used in this paper:
￿
ALT, alanine aminotransferase; AP, alkaline phosphatase;AST,
aspartate aminotransferase; GLDH, glutamate dehydrogenase; i.c., intracerebral; i.f., into the foot-
pad; LCM, lymphocytic choriomeningitis; LCMV, LCM virus; LU, lytic unit.
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Materials and Methods
Mice.
￿
Mice of either sex were used at an age of 8-16 wk. Inbred C57BL/6 (H-2''),
C57BL/10 (H-2°), B10.D2 (H-2d), B10.BR (H-2k), A/J (H-2a), ATL (H-2"), CBA/J (H-
2k), DBA/2 (H-2d), and BALB/c (H-2d), as well as outbred ICR +/+, nu/+, and nu/nu
mice were obtained from the Institut fur Zuchthygiene, Tierspital, Zurich. Inbred B10 .G
(H-29), B10.AKM (H-2"), DBA/1 (H-29), and AKR (H-2k) were purchased from OLAC,
Bichester, England; NMRI outbred mice were from Ivanovas, Kissleg, Federal Republic
of Germany. C57BL/6 +/+ and nu/nu mice were a gift of the Institut fur Medizinische
Forschung, Fullinsdorf, Switzerland.
Virus.
￿
The LCMV isolate WE was originally obtained from Prof. F. Lehmann-Grube,
Hamburg, Federal Republic of Germany, and was subsequently propagated on L929 cells
(1). LCMV-Armstrong was obtained as high-titered stock from Dr. M. Buchmeier, Scripps
Clinic and Research Foundation, La Jolla CA, (14). Virus dilutions were made in MEM
containing 1-5% of heat-inactivated FCS. The LCMV was either titrated in vivo in
footpads (6, 11) or in vitro on Vero cells (1).
Vaccinia virus (Lancy isolate) was purchased as a lyophilized stock from the Schweiz-
erisches Serum and Impfinstitut, Bern, Switzerland, and was usually dissolved in medium
with FCS to yield a stock solution containing 2 X 108 PFU/ml of virus.
Infection and Immunization.
￿
Mice were infected i.v. with 2 X 104-106 PFU of LCMV-
WE or with 105 PFU of LCMV-Armstrong (4, 5, 16).
Serum Sampling. Mice were anesthetized with ether; blood was obtained from the
retroorbital venous plexus using heparinized smooth-edged Natelson blood collecting
tubes (Fisher Scientific Co ., Pittsburgh, PA). In experiments where serum was collected
at only one time, mice were ether anesthetized and bled by cutting the thoracic inferior
vena cava and thereafter collecting blood from the thoracic cavity. The blood was
transferred to Microtainer tubes (Becton Dickinson, Rutherford, NJ) and processed.
Serum samples were analyzed individually or in pools of two to five donors.
Anti-IgM-treated Mice.
￿
Mice were injected i.p. with purified rabbit anti-mouse IgM
serum within 24 h after birth. They received 0.1 ml on days 1, 2, and 3, and thereafter
three times per week. The preparation of the antiserum, the housing of mice, as well as
the monitoring of suppression was performed as detailed previously (15).
Histology.
￿
Organs were fixed in PBS with 4% formalin for 1-2 d. Sections were stained
with H and E according to standard procedures.
Determination of Serum Enzyme Concentrations. AST (EC.2.6.1 .1), and ALT
(EC.2.6.1 .2) were determined according to the procedure of the International Federation
of Clinical Chemistry by a UV-absorbtion test (16, 17). GLDH (EC.1 .4.1 .3) was deter-
mined by a standard method as described (18). AP (EC.3.1 .3 .1) was determined according
to Bowers and McComb (19) usingp-nitrophenylphosphate as substrate. All reagents were
purchased from Boehringer Mannheim, Mannheim, Federal Republic of Germany. A
Hitachi 705 Selective analyser was used for the analyses (Hitachi Ltd., Nacka Works,
Japan).
In some experiments, mice were bled and enzyme concentrations were determined in
individual serum samples, and means ± SEM were determined. In other experiments,
equally sized blood samples from several mice were pooled and analyzed. Values of means
and SEM have been rounded up to the next 5 for values <50 U/liter, and to the next 10
for values >50 U/liter.
Cytotoxic T Cell Assay.
￿
The procedures have been described previously in detail (4, 5,
20). Briefly, single-spleen cell suspensions from C57BL/6 mice were incubated with 104
LCMV-infected or uninfected MC57G (H-26
, methylcholanthrene-induced established
cell line) or YAC (H-2a, a natural killer cell-susceptible thymoma line) target cells at
various ratios in round-bottomed 96-well plates (Petra Plastik; Inotech, Wohlen, Switzer-
land) for 5 h at 37°C in air supplemented with 5% C02. Specific
5`Cr-release from target
cells was calculated by correcting for spontaneous "Cr-release; maximal lysis was deter-
mined in wells containing targets treated with 1 N HCl but no effector cells . Lytic units
(LU), a measure of relative cytolytic activity, were determined according to established
methods (20, 21) to be the number of lymphocytes necessary to lyse one-third of theZINKERNAGEL ET AL.
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standard number of target cells (104 cells/well) during the standard test duration. LU per
spleen or liver were computed by dividing the total number of lymphocytes per organ by
LU (20, 21).
Isolation of Lymphocytes from Livers.
￿
All livers were processed individually and were
kept on ice. Single-cell suspensions were made by gently pushing the liver through a
stainless steel grid with a rubber-coated plastic syringe plunger. The resulting cell
suspension was washed twice in medium and divided into two 12-ml aliquots. Each aliquot
was underlayed with 10 ml of Ficoll-Hypaque solution (Seromed; Biochrom KG, Berlin,
Federal Republic of Germany) in a 40-ml glass tube. The tubes were spun at 2,500 g for
20 min in a Centra-7 centrifuge. Cells retrieved from the interface were washed twice in
medium, counted, and resuspended in the appropriate volume of medium for use in the
cytotoxic T cell assay.
Adoptive Transfer Experiments.
￿
Recipient mice were sublethally irradiated with 650
rad and injected with 105-106 PFU of LCMV-WE i.v. 5 d before transfusion. Donor mice
were infected either with 106 PFU of LCMV on day -8 or with 8 X 106 PFU of Vaccinia
virus on day -6. Donor mice were killed, and single-spleen cell suspensions were prepared
in balanced salt solution. Cell suspensions (1-2 X 108) were slowly transferred i.v. to
recipient mice in 0.5 ml.
Antisera Plus C' Treatment.
￿
Culture supernatants of the following mAb-producing cell
lines were used: rat anti-mouse Thy-1 .2 (HO 13-4-9) (22), rat anti-Lyt-2 (HO 2.2) (23),
and rat anti-L3T4 (GK 1 .5) (24). Usually, 3 ml of hybridoma supernatant were incubated
with 5 X 108 spleen cells for 30 min at VC. C. The cells were then washed and subsequently
incubated with 12 ml of Low-Tox rabbit serum (Cederlane Laboratories, Hornby,
Ontario, Canada) at a dilution of 1 :15 for 30 min at 37°C (25). Cells were treated twice.
C' controls were incubated with medium instead of antibody.
Nylon Wool Separation ofLymphocytes.
￿
The procedure ofJulius et al. (26) was used.
Determination ofLCMV Titers in Livers.
￿
Livers were homogenized in glass tubes with
Teflon pestles. The frozen and thawed samples were serially diluted 10-fold in medium
before 30 Al aliquots were injected into two footpads. Footpad swelling on days 7-9 was
recorded, and the greatest dilution still giving a positive reaction multiplied by the initial
dilution factor was taken as the titer of infectious doses (ID) of LCMV .
Results
Clinical Symptoms in Mice after i.v. Infection with LCMV.
￿
Dependent upon the
various parameters outlined in subsequent sections, young adult (6-12 wk of
age), immunocompetent mice showed no sign of disease up to day 6 or 7.
Between day 7 and day 10, mice infected with high doses of LCMV showed signs
of general malaise; they moved slowly, were hunched, had ruffled fur and
plepharitis. Occasionally mice died between day 12 and day 15, but overall
mortality was low (^-10%).
Measurements of Enzyme Levels in Serum after Infection of Mice with Different
LCMV Isolates. AST, ALT, GLDH, and AP enzyme concentrations in the serum
of outbred ICR and C57BL/6 mice were measured in individual mice on day 7
after infection with LCMV-WE or LCMV-Armstrong (Table I). Enzyme concen-
trations varied considerably from one mouse to the next in both infected groups,
and the uninfected group of mice . The means of the values obtained, or the
values determined in pools of serum samples from two to four mice (e.g., Tables
II and 111) usually showed great differences between infected and uninfected
groups, dependent upon the enzyme measured and various other parameters.
Mice infected with LCMV-Armstrong had AST, ALT, GLDH, and AP values
that were within normal ranges or were only slightly increased. In contrast, mice
infected with LCMV-WE showed serum enzyme values (means of values from1078
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Enzyme concentrations in serum (U/liter)
Mouse
strain
TABLE I
Comparison ofEnzyme Values in Serum ofMice Infected ix. for 7 d with 105 pfu of
LCMV-WE or LCMV-Armstrong
ICR
C57BL/6
* Meansand SEM were determined; means and SEM were rounded up to the next 10 (for values >50) or the next 5 (for values <50).
pooled sera) that were 10-15 times greater than normal for AST, 10-25 times
greater for ALT, and 10-12 times higher for GLDH . AP values were not
different from controls on day 7. These increased values signalled severe liver
cell damage triggered by LCMV-WE.
Dose Dependence.
￿
Changes in serum enzyme concentrations depended upon
the dose of LCMV-WE injected i.v. (Fig. 1). The increase of serum enzyme levels
correlated positively with the increased amount of LCMV injected ; with doses
<103 PFU, increases of serum values were small and very variable.
When doses >2 X 105 PFU of LCMV-WE were used for infection, enzyme
concentrations did not reach higher levels, but in contrast to when doses <2 X
105 PFU were used, they tended to stay elevated up to days 13-16.
Dependence upon Route of Infection.
￿
Outbred ICR and inbred C57BL/6 mice
were infected with 2 X 105 PFU of LCMV-WE into the footpad (i1) (30 Al), i.c .
(30 Al), i.v. (200 gl), or i.p . (200 j,1). Serum enzyme sample values were deter-
mined from blood collected on day 7 (data not shown) . Whereas injection i.v . or
i.p . caused the greatest increases in enzyme concentrations of AST, ALT, and
GLDH (10-20-fold increases), infection i.f. triggered no or only marginal in-
creases (i.e., 10-30%); after i.c. infection, enzyme levels reached intermediate
levels (4-7-fold increases).
Mouse Strain-dependence.
changes in serum enzyme
infection (Fig. 2). Increases
Different mouse strains varied with respect to
levels when analyzed 7 or 14 d after LCMV-WE
in concentration of ALT as well as AST and GLDH
LCMV
Measured
values
AST
Mean ±
SEM*
Measured
values
ALT
Mean n ± SEM
GLDH
Measured Mean t
values SEM
AP
Measured
values
Mean ±
SEM
WE 2,646 1,155 713 133
3,374 2,760 t 320 1,204 1,120 ± 70 474 530 t 90 70 110 f 20
2,261 987 400 119
Arm 133 63 41 70
238 180 ± 30 147 90 ± 30 67 45 ± 10 70 65 ± 5
182 53 33 56
None 119 52 39 77
203 150 ± 30 35 40 ± 10 35 40 ± 5 56 80 t 10
126 35 49 98
WE 861 658 205 84
2,737 1,670 ± 560 1,911 1,200 ± 370 625 390 t 130 140 110 t 20
1,428 1,043 352 112
Arm 119 35 32 119
147 140 ± 20 42 45 ± 10 34 35 ± 5 119 120 ± 2
168 56 45 126
None 98 21 30 322
140 110 ± 15 35 40 ± 10 37 35 ± 5 112 200 t 60
105 49 32 1683000
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TIME AFTER INFECTION (DAYS)
FIGURE 1 .
￿
Kinetics and virus dose-dependence of the changes in enzyme concentrations in
the serum of 1CR mice. Mice were injected with the indicated doses of LCMV ; two to four
mice were bled at the times indicated, and the enzyme levels determined in the serum .
FIGURE 2 .
￿
Mouse strain dependence of LCMV-triggered serum liverenzyme increases . Four
mice of various outbred (NMRI) or inbred strains (all others) were infected i.v . with 105 PFU
of LCMV-WE. On days 7 14, two mice were bled out and enzyme values were determined in
pooled sera (p); control sera were pooled from two uninfected mice (®).
10791050
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FIGURE 3 .
￿
Time course of hepatitis in immunocompetent and T cell-deficient mice. ICR
nu/+ (top) and ICR nu/nu (bottom) mice were infected i.v. with 2 X 105 PFU of LCMV-WE;
three to four mice were bled at each time point. Pooled sera were tested for AST (0, p) ALT
(A, A) and AP (". O).
were most pronounced in sera of outbred NMRI or ICR (not shown in Fig. 2,
but shown in Figs. 1 and 3) and in inbred A/J, concentration increases were
intermediate in those of inbred BIO.B R and C57BL/6, and rather low in CBA/J,
BALB/c, or DBA/2 mice. Significant increases in the serum enzyme levels of
ALT and GLDH were seen on day 7, and were normally smaller or not significant
on day 14 of infection; exceptions were BALB/c and DBA/2, which showed
increased levels of these enzymes on day 14 when compared with day 7 . AP
values were usually higher on day 14 than on day 7, and were highest in CBA/J
and NMRI mice. Thus with the same dose of LCMV-WE used to infect mice,
enzyme concentrations varied widely in different mouse strains. There was no
indication that the major histocompatibility gene complex H-2 influenced
LCMV-WE-dependent enzyme changes.
T Cell Dependence of AST, ALT, and GLDH Increases, and of Liver Tissue
Damage. A detailed analysis of the time course of enzyme concentrations found
in sera of outbred nu/nu and nu/+ ICR mice (Fig. 3) confirmed similar findings
(not shown) in C57BL/6 nu/nu and +/+ mice. ICR nu/nu mice infected i.v. with
2 X 105 PFU of LCMV-WE showed no measurable changes in serum concentra-
tions of the enzymes . In contrast, ICR nu/+ mice exhibited dramatic increases
of enzyme values by day 6; they peaked on day 6 for ALT, on day 8 for AST,ZINKERNAGEL ET AL .
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FIGURE 4 .
￿
Histology of livers from nu/nu ICR mice (A) or nu/+ mice (B) infected i.v . with
^-2 x 105 PFU of LCMV-WE 6 d previously . The sections are representative for the period
of most severe disease .
and fell rapidly after 8 d. AP values rose after day 6 and peaked around day 13
in ICR nu/+ .
The histological examination of liver sections from ICR nu/nu (Fig . 4a)
revealed no signs of inflammatory reactions at any of the times evaluated (2, 4,
6, 8, 10, 13, and 16 d) . In contrast, in nu/+ mice (Fig . 4 b) periportal mononuclear
infiltrates were associated with signs of focal liver cell destruction on days 6 and
8; also many lymphocytes were attached to the vascular endothelium . Similar
sections from uninfected control nu/+ mice were comparable to the one shown
from nu/nu mice . Histological signs of lymphocytic infiltrations and liver cell
destruction were observed in nu/+ mice mainly from days 6-8; thereafter they
decreased from days 10-13, and were absent on day 16 .
Antibody-independence ofLiver Damage.
￿
The results obtained with nu/nu and
nu/+ mice indicated that T cells were involved in causing both the histological
alterations in livers and the changes in enzyme concentrations in sera of infected
mice . A decisive contribution of T cell-dependent antibody responses was
excluded by the results obtained with B cell-depleted mice . Chronically anti-
IgM-treated mice were infected, shortly after birth, i.v . with LCMV-WE. Their
serum enzyme levels are compared in Table 11 . In all mice, enzyme values were
greatly increased when compared with uninfected controls, independent of
whether they had been treated with rabbit anti-mouse IgM serum. However,
after infection with LCMV-WE, anti-IgM-treated mice had greater AST, ALT,
and GLDH concentrations in the serum than untreated (Table 11, exp . 1) or
normal rabbit serum-treated mice (Table II, exp . 2) .
Correlation ofVirus Titer and Serum Enzyme Values with Cytotoxic T Cell Activities
in Liver .
￿
Two to three C57BL/6 mice were infected i.v . with 2 X 105 PFU of1082
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TABLE 11
Enzyme Values in Sera ofLCMV-WE-infected B Cell-depleted Mice
serum
Control values of unin-
￿
130-200
￿
40-60
￿
15-30
￿
50-90
fected anti-IgM-treated
mice
Mice had been treated with an affinity-purified rabbit anti-mouse IgM antiserum (see Materials
and Methods), or were left untreated; DBA/l were 14 wk old, ICR were 9 wk old at time of
infection.
* Sera from individual mice.
Serum pool from three mice.
LCMV-WE at various intervals before the assay; AST, ALT, and GLDH enzyme
concentrations in the serum, appropriate virus titers per liver, and cytotoxic T
cell activity in spleens were measured (Fig. 5). In addition, lymphocytes from the
liver were isolated on a ficoll-hypaque gradient; the number of lymphocytes
isolated and the cytotoxic activity found per liver paralleled all other parameters
that were determined after day 6. On day 4, only virus titers in livers were high,
but neither enzyme values in serum nor numbers of mononuclear cells that could
be isolated by ficoll separation, nor cytotoxic T cell activity in livers were above
background. Increases of enzyme concentration in serum and increases of
cytolytic T cell activity in spleens and livers were roughly parallel between days
6 and 10. LCMV titers in livers changed minimally from days 6-10, but then
decreased rapidly below detectable levels by day 12. In parallel with the disap-
pearance of LCMV, both enzyme values and cytotoxic T cell activities fell to low
or background values by days 13 and 16.
Thus the kinetics of effector Tcell appearance anddisappearance were delayed
by -3 d when compared with the growth curve of LCMV; once the virus was
eliminated by day 13, LCMV-specific T cells decreased rapidly in livers and
spleens and were not detectable any longer by day 16.
Cytotoxic TCell Activity ofInfammatory CellsIsolatedfrom Livers.
￿
When LCMV-
specific cytotoxic activities were monitored in spleens and livers of C57BL/6
mice infected with 3 X 10' or 3 X 105 PFU of LCMV 8 d after infection, the
dose responses shown in Fig. 6 were found. The effector cells were cytotoxic T
cells because they lysed infected histocompatible (MC57G, H-26) but neither
infected histoincompatible L929 (H-2'), nor uninfected target cells, nor NK-
susceptible YAC cells. In all examples tested, the relative activity of mononuclear
Exp. Mouse strain Treatment of
mice
Time after
infection
Enzyme
AST
concentrations in
ALT GLDH
serum
AP
d U/liter
1 DBA/1 Anti-IgM* 1,120 130 ND 50
Anti-IgM 1,540 360 100 20
None 6 780 80 80 80
None 720 100 ND 90
2 ICR Anti-IgM 1,800 410 320 190
Normal rabbit 9 1,380 260 100 110ZINKERNAGEL ET AL .
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FIGURE 5 .
￿
Comparison of the kinetics of LCMV in livers, liver enzyme concentration in
serum and cytotoxicT cell activity in spleens and livers . C57BL/6 mice were infected with 2
X 10 5 PFU of LCMV-WE i.v . at various times before the assay . Mice were bled out under
anaesthesia;serum enzyme levels were determined as detailed in Materialsand Methods (top).
Virus titers in liver (second panel) number of liver lymphocytes recovered after ficoll separation
and their cytolytic activity (third panel) and total lytic activity found in spleens weredetermined.
All values are the average of three mice .
cells isolated from livers was, on a cell-for-cell basis, two to five times greater
than that found in spleens from the same individual mice .
Adoptive Transfer of Liver Disease by T Cells.
￿
To evaluate which subpopulation
of T cells was involved in pathogenesis of LCMV-triggered immune hepatitis,
adoptive transfer experiments were performed . 8-d LCMV-WE-immune spleen
cells (2 X 108 ) from C57BL/6 mice were transferred to sublethally irradiated
(650 rad at -5 d) and LCMV-WE (106 PFU at -5 d)-infected recipient mice .
The enzyme concentrations in serum were compared to values measured in
identically pretreated mice that received 2 X 108 6-d Vaccinia virus-immune
spleen cells . The difference between these two values was caused by LCMV-1084 T CELL-MEDIATED HEPATITIS
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FIGURE 6.
￿
Cytotoxic T cell activity of mononuclear cells from livers and spleens. C57BL/6
mice (individuals A-D) were infected i.v. with the indicated dose of LCMV-WE, and 8 dlater
theirlymphocytes from spleen (0) and livers (0) were assayed forcytotoxicactivity on LCMV-
infected MC57G. No specific "Cr release was measured on infected L929 (H-2k) (p, A) or
YAC (O, 0) target cells; also normal spleen cells did not lyse infected MC57G. Spontaneous
release was <18% forall target cells used.
TIME PETER ADOPTIVE TRANSFER (hours)
FIGURE 7.
￿
LCMV-immune or Vaccinia virus-immune spleen cells (2 X 108 in 0.5 ml) were
injected i.v. into LCMV-WE infected (at -5 d) and irradiated (650 rad) recipient mice
(C57BL/6). Mice were bled at the indicated times; specific increase of enzyme concentration
was calculated as the difference between values obtained in recipients of LCMV-immune
minus those of recipients of Vaccinia-immune spleen cells. Actual values (U/liter) for the 16-
h time point were: forAST, (393 ± 38) - (68 ± 4); for ALT, (223 t 62) -(28 t 4); for GLDH,
(66 ± 11) - (8 ± 1). Enzyme levels (U/liter) of unmanipulated control C57BL/6 mice were:
AST, 60-100; ALT, 20-50; GLDH, 2-10.
specific T cells; the enzyme concentration values were found to increase in a
linear mode dependent upon time (Fig. 7).
Cell Dose and Time Dependence of Serum Enzyme Level Changes.
￿
Nylon wool-
nonadherent spleen cells were compared with unseparated spleen cells. 108 spleen
cells transfused i.v . into preinfected recipients induced serum enzyme level
increases comparable to those caused by 3 x 107 nylon wool-nonadherentCllfd es transerr
ZINKERNAGEL ET AL .
TABLE III
Characterization ofEffector Lymphocytes
Serum concentration of enzymes measured after transfer*
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" Donor mice were immunized with LCMV-WE (10' PFU i .v.) 8 d previously . Recipient mice were irradiated (650 rad) and injected with 2 X
106 PFU ofLCMV-WE 5d previously . Recipient mice were bled at the indicated time after cell transfer . MeanstSEM ofthree to five mice .
$ See Materials and Methods .
Measured 18 h after transfer only . The same treated effector T cells were tested in vitro for theircytolyticactivity at killer/target cell ratios
of 17, 6, and 2:1 during a 5-h assay. Percent specific "Cr release from infected target cells was : for cells treated with anti-Lyt-2 .2 + C, 15,
6, 1 ; with anti-L3T4+C, 75,77, and 36; and with C alone, 72, 50, and 24 . Spontaneous release was<25% ; maximal release from uninfected
targets<9% .
enriched T cells (Table IIIA). The dose- and time-dependent effect on serum
enzyme levels by nylon wool-nonadherent lymphocytes is shown in Table I .
Whereas 107 T enriched spleen cells caused a significant increase of serum
enzyme concentrations within 18 h, an augmentation of serum ALT andGLDH
(but not of AST) caused by the transfer of 3 x 106 cells could be assessed only
after 40 h .
Characterization of Effector T Cells .
￿
The effector cells causing the increase in
serum enzyme concentrations were identified as T cells by the following criteria :
they were nylon wool nonadherent (Table III), and they were susceptible to
treatment with anti-Thy-1 .2 plus C and anti-Lyt-2 plus C, but resistant to anti-
L3T4 plus C treatment (Table I1I) . LCMV-specific cytotoxic activity of 8-d
immune spleen cells treated with the various antibodies plus C was as expected ;
anti-Lyt-2 plus C treatment abrogated cytolysis by >95%, whereas anti-L3T4
plus C treatment enriched for cytolysic effectorT cell function when compared
with C treatment alone (Table III) . Cytotoxic activity measured in vitro corre-
lated with the capacity of the same cell populations to cause increases of serum
enzyme concentrations. Anti-Lyt-2 plus C-treated cells failed to induce substan-
tial increases, whereas anti-L3T4 plus C-treated cells caused ^-10-fold increases
of ALT and GLDH concentrations in serum of recipient mice .
Class 1 Restriction of Effector T Cells Mediating LCMV Hepatitis .
￿
The H-2
restriction of effector T cells causing liver cell destruction was assessed by
adoptive transfer (Table IV) of 8-d immune spleen cells into irradiated (650 rad
at -5 d) and preinfected (106PFU of LCMV-WE at -5 d) recipient mice .
To control for possible nonspecific effects on enzyme levels in LCMV-infected
and irradiated recipients by transferred LCMV-immune spleen cells, enzyme
Exp .
Treatment$ Number
Recovery
after
treatment
AST
18h 40h
ALT
18h 40h
GLDH
18h 40h
U/Liter
A 1 None None 2003 50 390 ± 90 60 ±30 80 ± 30 25 ±5 25 ±5
2 None 1 X 106 100 1,950 t380 2,370 t 340 1,530±340 1,180± 530 410t80 480t 160
3 Nylon wool- 3x 10' 30 1,830 t 150 1,970 t170 1,450t 130 1,050t 130 420t 30 450t30
4 passed 1 X 10' 700 t 140 1,070 ± 80 340t 140 430± 90 110t40 130t 30
5 3x 106 230 ± 70 590 t 80 100t 10 200t 20 40 ± 5 60 t 10
6 1 x 106 220± 60 500 t200 90 t40 100± 10 40 ± 10 50 t 20
B I Anti-Thy-1 .2 + 4 X 10' 40 250± 10011 ND 40 t5 ND 20±10 ND
2 C 4 x 10' 52 240± 10 ND 40±5 ND 20±10 ND
3 Anti-Lyt-2 .2 +C 4 X 10 7 60 610± 50 ND 340± 50 ND 120t 20 ND
4 Anti-L3T4+C 4 x 10' 83 1,040± 140 ND 390± 160 ND 130± 50 ND
5 C None 100 200t50 60 t 30 25 ± 5
Control1086
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TABLE IV
Specific Changes ofSerum Liver Enzyme Concentrations Caused by Adoptive Transfer ofLCMV
Immune vs. Vaccinia-immune Spleen Cells to LCMV-WE-infected Irradiated RecipientMice
Serum concentration (U/liter) of.
* 2 X 10' immune spleen cells from donormice infected i.v . with IOs PFU of LCMV-WE 8 d previously were transfused i .v. to recipient mice
that had been pretreated with 650 rad (-5 d), and infected with LCMV (108 i .v ., -5 d). Specific increase of enzyme levels in the serum was
calculated by subtraction ofenzyme values caused by adoptive transfer of2 X 10 8 6-d Vaccinia-immune spleen cells from those caused by 2
X 10' 8-d LCMV-immune spleen cells .
# Two to four mice per group were bled and individual sera were analyzed for enzyme concentrations; the numbers represent the average of
each group ± SEM .
values were compared with those ofmice transfused with Vaccinia virus-immune
spleen cells . When serum enzyme concentration values in sera from recipients of
Vaccinia-immune spleen cells were subtracted from the respective values found
in sera from recipients of LCMV-immune spleen cells, we found that H-2
compatibility for H-2D alone caused great increases in both examples tested
(Table IV, groups 2 and 7) ; recipients compatible only for H-21 did not show a
specific increase (Table IV, group 6) . H-2K-compatible effector spleen cells of
BIO.AKM origin caused a smaller increase in K'Ik-compatible BIO.BR recipients
(Table IV, group 3) than the same effector cells caused in K'IAk-compatible A/J
mice ; this may reflect a considerably greater increase of serum enzyme levels
caused byLCMV infection in immunocompetent A strain mice (Fig . 2) compared
with B 10 mice . Completely H-2-incompatible immune spleen cells did not cause
drastic changes of serum concentrations when compared with control mice that
did not receive immune cells (compare groups 4 and 9 in Table IV) .
Discussion
LCMV-induced, immunopathologically mediated hepatitis depends upon spe-
cific viral and host parameters . The hepatotrope LCMV-WE isolate but not the
neurotrope LCMV-Armstrong isolate causes hepatitis ; usually, higher doses cause
more severe disease . Infection i.v . or i.p . causes more severe disease than s .c .
infection . The host parameters influencing hepatitis include the general genetic
background of the mouse ; A, ICR, and NMRI mice are most susceptible, C57BL
and CBA intermediately susceptible, and BALB/c and DBA/2 mice least suscep-
Group
Donor H-2
KID
Recipient H-2
KID
H-2 compati-
bility
ALT ;
LCMV-
immune
cells transferred :
Vaccinia-
immune
Specific
increase*
GLDH ;
LCMV-
immune
cells transferred:
Vaccinia- Specific
immune increase
1 B10.AKM BIO.AKM K'I'Dq 760 t 430 40 t 10 720 150 ± 70 20 ± 5 130
kkq kkq
2 BIO.G DQ 670 ± 110 60 ± 10 610 120 ± 20 20 f 5 90
qqq
3 B10.BR Kklk 200 t 100 80 ± 10 120 40 t 10 25 ± 5 15
kkk
4 BIO.D2 none 60±20 70±20 <1 20±10 25 f5 <1
ddd
5 A/J Kklk 1,100 t 150 290 t 140 810 480 ± 30 200 ± 100 280
kkdd
6 A.TL Ik 70 ± 10 180 t 30 <1 80 f 5 90 t 10 <1
skd
7 BIO.D2 A/J Dd 1,240 t 80 280 f 30 960 410 ± 20 90 ± 5 320
child kkdd
8 None BIO.AKM - 50 t 20 60 t 20 <1 40 t 20 40 t 10 <1
9 None B10.D2 - 60 t 20 60 t 10 <1 30 ± 10 25 t 5 <IZINKERNAGEL ET AL.
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tible to LCMV-WE hepatitis; however, no influence of the murine major histo-
compatibility gene complex H-2 on susceptibility to LCMV-hepatitis has been
found so far. A further crucial factor is the immunocompetence of the host,
since euthymic mice do, while nude mice do not develop hepatitis; B cells and
antibodies are not significantly involved, whereas activity of cytotoxic T cells
parallels histological abnormalities in liver and changes of enzyme (AST, ALT,
GLDH) concentrations in serum. Most symptoms of hepatitis fade in parallel
with the clearance of virus and the rapid decrease of T cell activities. Mononu-
clear cells with cytotoxic T cell activity, but lacking NK activity, can be isolated
from livers during the period of most florid hepatitis; when compared on a cell-
for-cell basis, cytotoxic mononuclear cells from livers were relatively more active
than spleen cells.
The presented results extend the classical studies on LCM disease describing
clinical symptoms of systemic LCMV infections in mice, such as LCMV-induced
wasting disease (1, 2) or hematological disorders (8). In nearly all instances,
immune mechanisms mediated by T cells were shown to be responsible for the
pathology; in few examples has a direct effect of LCMV on selected cellular
functions been demonstrated (27). However, only in the case of LCMV-induced
choriomeningitis have cytotoxic T cells been implicated directly (3, 4, 28, 44).
Our analysis of LCMV-induced hepatitis illustrates that, here also, T cell-
dependent and/or -mediated cell and tissue damage is responsible for disease
rather than the virus itself. This is in contrast to other murine hepatitis forms
caused by ectromelia virus (mousepox [29]) and probably also by murine hepatitis
virus (MHV) (30) infections, which are mainly caused by the direct cytopathic
effect of the virus itself. The model disease described here resembles in some
aspects acute hepatitis B virus infections in humans (11-13), but differs in others.
Hepatitis B virus and LCMV are poorly or noncytopathic (1, 2, 31), may be
transmitted from mother to offspring (1, 2, 32) and may establish a virus carrier
status in either newborn or adult individuals without causing clinical symptoms
(11, 12). Also, in both infections, liver cell damage does not correlate with virus
titers in liver or blood, but rather with the T cell immune response in mice and
the presumably T cell-dependent IgG anti-hepatitis B surface antigen response
in humans (11, 12, 50-54) .
Over the past two decades, it has been repeatedly postulated that hepatitis B
is immunologically mediated (26-28, 33-37). Several observations have sup-
ported this claim. Clinical symptoms usually become manifest at about the time
when levels ofhepatitis B surfaceantigens begin to fall, signalling successful virus
elimination (12, 13, 34-37). Indirect evidence is provided by the finding that
susceptibility to some forms of hepatitis B is weakly linked to major transplanta-
tion antigens (38). Furthermore, immunosuppression with lymphocytotoxic
drugs may, dependent upon the particular equilibrium established in a patient
between virus spread and immune response, temporarily improve signs of ag-
gressive hepatitis (39) or alternatively, may induce or reactivate it (40) . Also,
transfer of HLA nonmatched hepatitis B-immune white blood cells to hepatitis
B virus carriers has been shown in one study (41) to cause a rapid but only
temporary increase of several liver enzymes in the blood of the recipient.
Cytotoxic virus-specific T cells have been searched for in the human disease
but only with limited success so far. Possibly this may be because of at least three1088
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reasons: hepatitis B virus is difficult to grow in tissue cultured cells in vitro (31,
42), the direct isolation ofvirus-specific cytotoxic T cells from peripheral blood
is in general only rarely possible (43), and induction of secondary hepatitis B-
specific cytotoxic Tcells in vitro has not yet been achieved.
Obviously, the presented mouse model of T cell-mediated LCMV hepatitis
differs in many otheraspects from human hepatitis B infections. The incubation
time in hepatitis B seems to be dose dependent and is usually long (weeks to
months). After i.v. infection ofLCMV, the incubation period ofhepatitis in mice
is 6-9 d, and this incubation time is influenced only marginally by the dose of
virus used. Another clinically important feature of hepatitis B not found in
LCMV hepatitis of ICR or C57BL/6 mice is the form of chronic, aggressive
hepatitis; the established model of LCMV-hepatitis corresponds more to an acute
form of hepatitis B. It will be of great interest to evaluate in this murine model
both viral and host factors thatmay influence the balance between LCMV spread
and immune response, and which may cause more chronic forms ofhepatitis.
The present study also demonstrates as directly as possible that virus-specific
T cells that are cytotoxic in vitro act cytolytically in vivo. When infected with
the hepatotropic LCMV-WE isolate, a great number of host cells, including liver
cells, are infected and therefore can serve as target cells in vivo for adoptively
transferred LCMV-specific effector T cells. Since liver cells store a number of
characteristic enzymes, which are released,upon cytolysis, enzyme release could
be used as an indication for cell death (44). Because of the potentially great
number of available infected liver target cells, the resulting signal was great
enough to be measurable within a relatively short time after adoptive transfer of
cells to LCMV-infected immunosuppressed recipient mice. Adoptive transfer of
nylon wool-nonadherent, Thy-1,+ and Lyt-2,' L3T4,- class I- but not class II-
MHC-restricted, and virus-specific cytotoxic Tcells to irradiated and preinfected
recipients led toa cell dose-and time-dependent linear increase ofthese enzymes
in the serum. The linear time dependence of the serum enzyme changes after
transfer suggests that effector T cells destroy infected liver cells in vivo in the
same way as T cells lyse "Cr-labelled infected target cells in vitro (21). Both
types of label releases follow a single-hit kinetics, signalling target cell destruction
by cell contact rather than by soluble mediators (45-47).
The experimental design makes it improbable that lymphohemopoietic cells
otherthan Lyt-2+, L3T4- class I MHC-restricted T cellscontributed significantly
to the destruction of infected liver cells. Recipient mice had been irradiated with
650 rads, and therefore did notpossess many lymphohemopoieticcells, including
macrophages 5-6 d after irradiation. In addition, nylon wool-purified T cells
that lacked great numbers of macrophages or B cells transferred hepatitis
successfully in a class I-restricted fashion rapidly after transfer.
The question of how cytotoxic T cells mediate their effector function in vivo
has been addressed repeatedly by analysis of the effect of purified or cloned
cytotoxic T cells in vivo in various murine tumor and infectious disease models
(20, 21, 28, 48, 49). Antiviral protection measured by virus titer reduction or
prevention of titer increases may be interpreted to reflect direct host cell
destruction during the eclipse phase of virus infection. This correlation was
demonstrated in vitro by the finding that the "Cr-release from acutely infected
target cells paralleled blocking of generation of virus progeny (20, 49). TumorZINKERNAGEL ET AL.
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cell destruction by cytotoxic Tcells was shown by labelling tumor cells and then
examining the excretion of the radioactive label (50). Cytotoxic T cells could be
shown to cause rapid radiolabel excretion when both tumor cells and T cells
were given i.p. When tumor cells were given i.p. and T cells i.v., label excretion
was considerably slower and more difficult to measure accurately during the first
24-48 h, because of the background release of the label and because of the
relatively smallersignal. Bothofthese technical problems have been considerably
reduced in this study by using infected liver cells as target cells. In this physio-
logical model, the background was low and stable, and many infected target cells
were available and accessible to recirculating effector T cells.
Because of the experimental conditions chosen, the obtained results, particu-
larly the time-dependent linear increase ofliver enzyme levels in serum, represent
the most direct evidence to date that cytotoxic effector T cells are directly
responsible for enzyme release from LCMV-infected liver cells, and therefore
that they act cytolytically in vivo.
Summary
A model for immunologically T cell-mediated hepatitis was established in
mice infected with lymphocytic choriomeningitis virus (LCMV). The severity of
hepatitis was monitored histologically and by determination ofchanges in serum
levels of the enzymes alanine aminotransferase (ALT), aspartate aminotrans-
ferase (AST), glutamate dehydrogenase (GLDH), and alkaline phosphatase (AP).
Kinetics of histological disease manifestations, increases of liver enzyme levels in
the serum, and cytotoxic Tcell activities in livers and spleens all correlated and
were dependent upon several parameters: (a) LCMV-isolate; LCMV-WE caused
extensive hepatitis, LCMV-Armstrong virtually none. (b) Virus dose. (c) Route
of infection; i.v. or i.p. infection caused hepatitis, whereas infection into the
footpad did not. (d) The general genetic background ofthe murine host; of the
strains tested, Swiss mice and A-strain mice were more susceptible than C57BL
or CBA mice; BALB/c and DBA/2 mice were least susceptible. (e) The degree
of immunocompetence of the murine host; T cell deficient nu/nu mice never
developed hepatitis, whereas nu/+ or +/+ mice always did. B cell-depleted anti-
IgM-treated mice developed immune-mediated hepatitis comparably or even
more extensively than control mice. (f) Local cytotoxic T cell activity; mono-
nuclear cells isolated from livers during the period of overt hepatitis were two
to five times more active than equal numbers ofspleen cells.
Adoptive transfer ofnylon wool-nonadherent anti-Thy-1 .2andanti-Lyt-2 plus
C-sensitive, anti-L3T4 plus C-resistant lymphocytes into irradiated mice prein-
fected with LCMV-WE caused a rapid time- and dose-dependent linear increase
of serum enzyme levels. This increase was caused by adoptive transfer of
lymphocytes if immune cell donors and recipient mice shared class I, but not
when they shared class II histocompatibility antigens. The donor cell dose-
dependent increase of these enzymes was first measurable 6-18 h after transfer
with 2 X 108 cells or 3 X 106 cells, respectively . The time-dependent increase
caused by the adoptive transfer of 1-2 X 108 cells was strictly linear during a
period of up to 25-40 h. These results indicate single-hit kinetics of liver cell
death and suggest that effector T cells destroy infected liver cells via direct
contact rather than via soluble toxic mediators. The results may represent the1090
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best in vivo correlate of the in vitro
51 Cr-release assay that has been analyzed so
far, and strongly support the view that antiviral cytotoxic T cells are directly
cytolytic in vivo.
Thus LCMV-WE-induced hepatitis in mice is an immunopathologically medi-
ated disease caused by T cell-mediated destruction of infected liver cells. Overall,
this disease parallels many aspects of acute viral hepatitis in humans, which is
caused by hepatitis B virus.
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